Chester County News and Community Website
EXTON, PA — Lungpacer Medical Inc. is commercializing an FDA-approved diaphragm stimulation system at U.S. hospitals to help critically ill patients discontinue mechanical ventilation, positioning its technology to address complications …
Lungpacer Expands ICU Reach With FDA-Approved Breathing Device Read More EXTON, PA — Lungpacer Medical said a new economic analysis projects its AeroPace diaphragm-stimulation system could reduce hospital and post-acute care costs by about $24,000 per patient before device expenses, …
Lungpacer Study Projects $24,000 Savings Per AeroPace Case Read More EXTON, PA — Lungpacer Medical secured three new medical billing codes for its AeroPace diaphragm neurostimulation system effective July 1, advancing the company’s effort to establish broader reimbursement for hospitals …
Lungpacer Gains CPT Codes to Advance AeroPace Reimbursement Read More
EXTON, PA — Lungpacer Medical says physicians at one of the nation’s largest healthcare systems have completed the first commercial procedures using its FDA-approved AeroPace System, marking a pivotal step …
ICU Breakthrough: First Patients Breathe Free With Lungpacer’s AeroPace Read More EXTON, PA — Lungpacer Medical, Inc. has announced pivotal results from the RESCUE-3 trial, published in the American Journal of Respiratory and Critical Care Medicine, showcasing the groundbreaking benefits of …
Lungpacer Medical Publishes Landmark Findings on AeroPace System in Critical Care Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced its strategy to secure 7.5 years of U.S. exclusivity for istaroxime, its investigational treatment for cardiogenic shock, if approved by the …
Windtree Therapeutics Unveils U.S. Exclusivity Strategy for Istaroxime Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced that its AC3 Range™ Intra-Aortic Balloon Pump (IABP) has received FDA 510(k) clearance. Designed for seamless intra-aortic balloon pumping across various modes …
Teleflex Secures FDA Clearance for AC3 Range IABP, Enhancing Cardiac Patient Transport Read More EXTON, PA — Lungpacer Medical has unveiled promising results from its groundbreaking STIMULUS trial, a Phase 1 study conducted in collaboration with Toronto General Hospital. Presented at the 2025 Transcatheter Heart …
Lungpacer Medical Shares Promising Results from STIMULUS Trial Read More